| ²é¿´: 165 | »Ø¸´: 0 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
[×ÊÔ´]
¼ÓÄôó·ÂÖÆÒ©É걨Êý¾ÝÇåµ¥-Summary of Submitted Data
|
||
|
Ŀ¼ÈçÏ£º 1.0 Information On Test Product 2.0 Information On Reference Product 3.0 Identification of Drug Characteristics and Dosage form Properties 4.0 Study Specific Product Information 5.0 Bioavailability Study Background Information 6.0 Summary of Study Design and Subject Information 7.0 Information on the Analytical Methodology and Analysis of Subject Samples 8.0 Summary of Drug Disposition and Pharmacokinetic Analysis ÏÂÔØµØÖ·£ºhttp://www.namipan.com/d/SUMMARY ... a46e2d7f50bd69d0000 |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ÌìÖÐÒ½ÖÐҩѧר˶£¬Ï£ÍûÓÐbÇøµÄÀÏʦ¿ÉÒÔ¿¼ÂÇÒ»ÏÂÎÒ
ÒѾÓÐ1È˻ظ´
µ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ251È˻ظ´
ҩѧѧ˶326Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
26Ä격ʿÉêÇë
ÒѾÓÐ20È˻ظ´
Ò©Àíѧ¡¢ÁÙ´²Ò©Ñ§·½Ïò µ÷¼Á
ÒѾÓÐ1È˻ظ´
ÇóÖú ±½Á×Áò°·JP
ÒѾÓÐ0È˻ظ´
100½ð±Ò °¢ÄªÎ÷ÁÖ¿ËÀάËá¼ØÆ¬BPÒ©µäÖÐÌáµ½µÄ¿ËÀάËá¾ÛºÏÎï¾ßÌå½á¹¹Ê½ÊÇɶ£¿
ÒѾÓÐ2È˻ظ´
ÉÅʳ²¹³ä¼ÁºÏ¹æÐÔ½»Á÷
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸Õã´óҩѧÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
¸ßθßѹ·´Ó¦ÇóÖú
ÒѾÓÐ4È˻ظ´














»Ø¸´´ËÂ¥